Short Interest in Edap Tms S.A. (NASDAQ:EDAP) Drops By 18.1%

Edap Tms S.A. (NASDAQ:EDAP - Get Free Report) saw a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 94,100 shares, a decline of 18.1% from the March 31st total of 114,900 shares. Currently, 0.3% of the company's shares are sold short. Based on an average daily volume of 117,800 shares, the short-interest ratio is presently 0.8 days.

Edap Tms Stock Up 6.0 %

Shares of NASDAQ:EDAP traded up $0.13 during trading on Wednesday, reaching $2.28. 85,618 shares of the stock were exchanged, compared to its average volume of 100,110. Edap Tms has a 1-year low of $1.26 and a 1-year high of $7.30. The stock has a fifty day moving average of $1.98 and a two-hundred day moving average of $2.28. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The firm has a market cap of $84.60 million, a price-to-earnings ratio of -3.51 and a beta of 0.13.

Edap Tms (NASDAQ:EDAP - Get Free Report) last issued its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.06. The firm had revenue of $22.69 million during the quarter, compared to analysts' expectations of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. Research analysts anticipate that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently issued reports on EDAP. Piper Sandler dropped their price target on shares of Edap Tms from $5.00 to $4.50 and set an "overweight" rating for the company in a research note on Friday, March 28th. Jefferies Financial Group reaffirmed a "hold" rating and set a $2.00 target price (down from $8.00) on shares of Edap Tms in a report on Friday, April 4th. StockNews.com initiated coverage on Edap Tms in a research note on Wednesday. They issued a "hold" rating for the company. Finally, HC Wainwright reiterated a "buy" rating and set a $19.00 price objective on shares of Edap Tms in a research report on Friday, March 28th.

Institutional Trading of Edap Tms

Several institutional investors and hedge funds have recently made changes to their positions in the company. Cetera Investment Advisers grew its position in Edap Tms by 33.9% during the first quarter. Cetera Investment Advisers now owns 75,000 shares of the medical equipment provider's stock valued at $147,000 after buying an additional 19,000 shares during the period. Illumine Investment Management LLC bought a new stake in shares of Edap Tms in the 4th quarter worth approximately $50,000. Rock Springs Capital Management LP lifted its stake in Edap Tms by 1.5% in the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider's stock valued at $3,518,000 after purchasing an additional 23,800 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Edap Tms by 111.5% during the fourth quarter. BNP Paribas Financial Markets now owns 48,650 shares of the medical equipment provider's stock valued at $108,000 after purchasing an additional 25,650 shares during the period. Finally, Millennium Management LLC grew its holdings in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider's stock valued at $108,000 after purchasing an additional 33,558 shares during the period. Hedge funds and other institutional investors own 62.74% of the company's stock.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.